Phosphodiesterase 5 inhibitor use and incident diabetic retinopathy in men with erectile dysfunction and type 2 diabetes: a propensity-matched cohort study.
BACKGROUND/OBJECTIVES To evaluate the association between phosphodiesterase type 5 inhibitor (PDE5I) use and incident diabetic retinopathy (DR) among men with erectile dysfunction (ED) and type 2 diabetes (T2D). SUBJECTS/METHODS Male patients aged ≥50 years with ED and T2D were identified from the TriNetX global elec...